2023-01-25 08:34:00

Invitation to presentation of BioArctic's fourth quarter report for October - December 2022 on October 20 at 9.30...

Logo PR Newswire
PR Newswire

STOCKHOLM, Jan. 25, 2023 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company's fourth quarter report for October - December 2022 on Friday, February 3, 2022, at 08:00 a.m. CET.

In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on February 3, at 09:30 CET, where Gunilla Osswald, CEO, and Jan Mattsson, CFO, will present BioArctic and comment on the fourth quarter report for October – December 2022, followed by a Q&A-session.

If you wish to participate via webcast, please use the link below. Via the webcast you are able to ask written questions. Webcast: https://ir.financialhearings.com/bioarctic-q4-2022/register

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference. https://conference.financialhearings.com/teleconference/?id=5008079

The webcast will also be available on demand on BioArctic's corporate website https://www.bioarctic.se/en/section/investors/presentations/ after the presentation.

For more information, please contact:
Oskar Bosson, VP Communications and Investor Relations, BioArctic AB
E-mail: oskar.bosson@bioarctic.se
Tel: + 46 704 10 71 80

This information was submitted for publication at 08:30 a.m. CET on January 25, 2023.

About BioArctic AB
BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. BioArctic focuses on innovative treatments in areas with high unmet medical needs. The company was founded in 2003 based on innovative research from Uppsala University, Sweden. Collaborations with universities are of great importance to the company together with its strategically important global partner Eisai in Alzheimer disease. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and out-licensing potential. BioArctic's Class B share is listed on Nasdaq Stockholm Large Cap (ticker: BIOA B). For more information about BioArctic, please visit www.bioarctic.com.

The following files are available for download:

https://mb.cision.com/Main/9978/3702444/1800394.pdf

Invitation to presentation of BioArctics Fourth Quarter Results October - December 2022

Cision View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-bioarctics-fourth-quarter-report-for-october---december-2022-on-october-20-at-9-30-am-cet-301730141.html

Logo PR Newswire
REDDITCH, England, Jan. 25, 2023 /PRNewswire/ -- Concentric's Interim Report for Q4 (January- December 2022 ), will be published on the 8 of February 2023,...

Logo PR Newswire
HealthPress Release2023-01-24 12:00:00
REHOVOT, Israel, Jan. 24, 2023 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics,...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-01-24 19:10:00
- Wednesday, January 25, 202 3 1 0 : 50 am 11:20am EST - Discussion of the Biotech Showcase Conference BOSTON, MASSACHUSETTS, Jan. 24, 2023 (GLOBE NEWSWIRE)...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
CARMEL, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide...

Logo GlobeNewswire
SciencePress Release2023-01-24 12:00:00
BOCA RATON, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (First Wave BioPharma or the Company), a clinical-stage...

Logo PR Newswire
CHICAGO, Jan. 24, 2023 /PRNewswire/ -- CNA Financial Corporation (NYSE: CNA) will report fourth quarter 2022 results before the market opens on Monday,...

Logo PR Newswire
GOTHENBURG, Sweden, Jan. 25, 2023 /PRNewswire/ -- On Monday, 13 February at 8:00 a.m. (CET), Castellum will publish its year-end report 2022. Investors,...

Logo PR Newswire
DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "Global DNA-RNA Sample Preparation Market (2022-2027) by Type, Application, End User, and Geography, Competitive...

Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...

Logo PR Newswire
MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer...

Logo The Business Journals
Politics2023-01-24 19:32:43
It could be a signal that 2023 is shaping up to be another rough year for the biotech industry.

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 21:21:00
EPR Properties EPR announced today that the Company will release its fourth quarter 2022 financial results after the market close on Wednesday, February 22,...

Logo GlobeNewswire
EconomyPress Release2023-01-24 15:00:00
Biohacking Market Trends and Insights Type (Inside, Outside), Product (Smart Drugs, Sensors, Strains), Application (Synthetic, Genetic Engineering), End-user...

Logo GlobeNewswire
EconomyPress Release2023-01-24 13:47:00
[115+ Pages Research Study] According to Polaris Market Research report, the global biorational market size & share expected to generate revenue cap of...

Logo PR Newswire
HealthPress Release2023-01-25 08:02:00
STOCKHOLM, Jan. 25, 2023 /PRNewswire/ -- Sedana Medical AB (publ) (the "Company" or "Sedana Medical") announced on 19 January 2023 that Nasdaq Stockholm's...

Logo EIN Presswire
CAMBRIDGESHIRE, UK, January 24, 2023 / EINPresswire.com / -- Microban International is thrilled to be attending PLASTINDIA 2023, one of the largest...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 21:06:00
Mattel, Inc. MAT today announced that it plans to release its fourth quarter and full year 2022 financial results on Wednesday, February 8, 2023, at...

Logo Nasdaq
TechnologyBy Zacks2023-01-24 13:00:00
Cathie Wood, famous for the success of Ark Investments winning products, had created a great fan following in 2021 only to witness a miserable fate in 2022....

Logo PR Newswire
TechnologyPress Release2023-01-24 21:03:00
SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Lumentum Holdings Inc. ("Lumentum") today announced that management will host the " LITE 2023 : L umentum I...

Logo GlobeNewswire
TechnologyPress Release2023-01-24 21:30:00
Conference Call Scheduled for 5:00 p.m. ET on February 23, 2023 AUSTIN, Texas, Jan. 24, 2023 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (BigCommerce)...